Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17894837rdf:typepubmed:Citationlld:pubmed
pubmed-article:17894837lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C0039730lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C0017258lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C0439793lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C0005221lld:lifeskim
pubmed-article:17894837lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:17894837pubmed:issue6lld:pubmed
pubmed-article:17894837pubmed:dateCreated2007-11-16lld:pubmed
pubmed-article:17894837pubmed:abstractTextWe evaluated the contribution of 67 single nucleotide polymorphisms (SNPs) within the beta-globin gene cluster to disease severity in groups of 207 mild- and 305 severe unrelated patients from Thailand with Hemoglobin E (HbE)/beta(0)-thalassemia and normal alpha-globin genes. Our analysis showed that these SNPs comprise two distinct linkage disequilibrium blocks, one containing the beta-globin gene and the other extending from the locus control region (LCR) to the delta gene, which are separated by a recombination hotspot in the narrow region of the beta-globin gene promoter. Forty-five SNPs within the interval including the LCR region and the delta gene showed strong association with disease severity. The strongest association was observed with the XmnI polymorphism located 158-bp upstream to the G gamma gene (p = 4.6E-12). Carriers of the T allele of XmnI were more likely to have a milder disease course and higher level of fetal hemoglobin (HbF) in both the mild (p = 0.005) and severe (p = 8.7E-06) patient groups. Haplotype analysis revealed that the T allele of XmnI was nearly always in cis with the HbE allele. The high frequency of this haplotype may be favored by positive selection against malarial infection. Further studies are needed to validate this hypothesis and determine whether XmnI or another closely linked variant modulates severity and HbF levels in patients with beta(0)-thalassemia/HbE disease.lld:pubmed
pubmed-article:17894837pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17894837pubmed:languageenglld:pubmed
pubmed-article:17894837pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17894837pubmed:citationSubsetIMlld:pubmed
pubmed-article:17894837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17894837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17894837pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17894837pubmed:statusMEDLINElld:pubmed
pubmed-article:17894837pubmed:monthDeclld:pubmed
pubmed-article:17894837pubmed:issn0009-9163lld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:BraunAAlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:AbelKKlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:MOGGlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:WinichagoonPPlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:FucharoenSSlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:FarrerL ALAlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:Angkachatchai...lld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:WhitacreJJlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:SripichaiOOlld:pubmed
pubmed-article:17894837pubmed:authorpubmed-author:MakarasaraWWlld:pubmed
pubmed-article:17894837pubmed:issnTypePrintlld:pubmed
pubmed-article:17894837pubmed:volume72lld:pubmed
pubmed-article:17894837pubmed:ownerNLMlld:pubmed
pubmed-article:17894837pubmed:authorsCompleteYlld:pubmed
pubmed-article:17894837pubmed:pagination497-505lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:meshHeadingpubmed-meshheading:17894837...lld:pubmed
pubmed-article:17894837pubmed:year2007lld:pubmed
pubmed-article:17894837pubmed:articleTitleBeta-globin gene cluster polymorphisms are strongly associated with severity of HbE/beta(0)-thalassemia.lld:pubmed
pubmed-article:17894837pubmed:affiliationDepartment of Medicine (Genetics Program), Boston University School of Medicine, Boston, MA 02118, USA.lld:pubmed
pubmed-article:17894837pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17894837pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17894837pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:3043entrezgene:pubmedpubmed-article:17894837lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17894837lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17894837lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17894837lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17894837lld:pubmed